BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25701535)

  • 1. Transabdominal contrast-enhanced ultrasound imaging of the prostate.
    Mischi M; Demi L; Smeenge M; Kuenen MP; Postema AW; de la Rosette JJ; Wijkstra H
    Ultrasound Med Biol; 2015 Apr; 41(4):1112-8. PubMed ID: 25701535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-D Quantitative Dynamic Contrast Ultrasound for Prostate Cancer Localization.
    Schalk SG; Huang J; Li J; Demi L; Wijkstra H; Huang P; Mischi M
    Ultrasound Med Biol; 2018 Apr; 44(4):807-814. PubMed ID: 29395678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.
    Wildeboer RR; Mannaerts CK; van Sloun RJG; Budäus L; Tilki D; Wijkstra H; Salomon G; Mischi M
    Eur Radiol; 2020 Feb; 30(2):806-815. PubMed ID: 31602512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-D spatiotemporal analysis of ultrasound contrast agent dispersion for prostate cancer localization: a feasibility study.
    Schalk SG; Demi L; Smeenge M; Mills DM; Wallace KD; de la Rosette JJ; Wijkstra H; Mischi M
    IEEE Trans Ultrason Ferroelectr Freq Control; 2015 May; 62(5):839-51. PubMed ID: 25965678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer.
    Postema AW; Frinking PJ; Smeenge M; De Reijke TM; De la Rosette JJ; Tranquart F; Wijkstra H
    BJU Int; 2016 Apr; 117(4):598-603. PubMed ID: 25754526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of transrectal ultrasound imaging of the prostate.
    Aigner F; Mitterberger M; Rehder P; Pallwein L; Junker D; Horninger W; Frauscher F
    J Endourol; 2010 May; 24(5):685-91. PubMed ID: 20433367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MR detection of local prostate cancer recurrence after transrectal high-intensity focused US treatment: preliminary results].
    Ben Cheikh A; Girouin N; Ryon-Taponnier P; Mège-Lechevallier F; Gelet A; Chapelon JY; Lyonnet D; Rouvière O
    J Radiol; 2008 May; 89(5 Pt 1):571-7. PubMed ID: 18535498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound.
    Ito H; Kamoi K; Yokoyama K; Yamada K; Nishimura T
    Br J Radiol; 2003 Sep; 76(909):617-24. PubMed ID: 14500276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
    Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer.
    Wildeboer RR; Postema AW; Demi L; Kuenen MPJ; Wijkstra H; Mischi M
    Eur Radiol; 2017 Aug; 27(8):3226-3234. PubMed ID: 28004162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative perfusion analysis in pancreatic contrast enhanced ultrasound (DCE-US): a promising tool for the differentiation between autoimmune pancreatitis and pancreatic cancer.
    Vitali F; Pfeifer L; Janson C; Goertz RS; Neurath MF; Strobel D; Wildner D
    Z Gastroenterol; 2015 Oct; 53(10):1175-81. PubMed ID: 26480053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-D Multi-parametric Contrast-Enhanced Ultrasound for the Prediction of Prostate Cancer.
    Wildeboer RR; van Sloun RJG; Huang P; Wijkstra H; Mischi M
    Ultrasound Med Biol; 2019 Oct; 45(10):2713-2724. PubMed ID: 31300222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of three-section contrast-enhanced transrectal ultrasonography in the detection of prostate cancer.
    Qi TY; Sun HG; Li NF; Feng H; Ding YL; Wang XX
    J Clin Ultrasound; 2017 Jun; 45(5):304-309. PubMed ID: 28186627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
    Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
    Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.
    Arteaga-Marrero N; Rygh CB; Mainou-Gomez JF; Nylund K; Roehrich D; Heggdal J; Matulaniec P; Gilja OH; Reed RK; Svensson L; Lutay N; Olsen DR
    Contrast Media Mol Imaging; 2015; 10(6):428-37. PubMed ID: 26010530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transverse prostate measurement obtained using transabdominal ultrasound: possible role in transurethral needle ablation of the prostate.
    Doebler RW
    Urology; 2000 Apr; 55(4):564-7. PubMed ID: 10736504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.